Observational cohorts of TPE in severe COVID-19 have reported substantial reductions in IL-6, CRP, erythrocyte sedimentation rate, and other acute-phase reactants after one or more sessions, but often with persistently high mortality, raising the possibility that biochemical improvements do not consistently translate into survival benefit [11]. This evidence concerns the gene IL6 and COVID-19.